{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:13:41Z","timestamp":1788606821098,"version":"build-2803163510"},"reference-count":139,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ihj.2026.08.008","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:49:19Z","timestamp":1788364159000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multi-omics based biomarkers in acute coronary syndrome: Towards precision in cardiovascular medicine"],"prefix":"10.1016","author":[{"given":"Yash Paul","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3554-8126","authenticated-orcid":false,"given":"Ankur","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kraticka","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveena","family":"N","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juniali","family":"Hatwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshyaya","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6945-8392","authenticated-orcid":false,"given":"Ashish","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bishav","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7606-5826","authenticated-orcid":false,"given":"Akash","family":"Batta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ihj.2026.08.008_bib1","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.3390\/ijerph20095633","article-title":"Challenges and burdens in the coronary artery disease care pathway for patients undergoing percutaneous coronary intervention: a contemporary narrative review","volume":"20","author":"Kodeboina","year":"2023","journal-title":"Int J Environ Res Publ Health"},{"issue":"6","key":"10.1016\/j.ihj.2026.08.008_bib2","doi-asserted-by":"crossref","first-page":"210","DOI":"10.31083\/j.rcm2306210","article-title":"Secondary prevention after myocardial infarction: what to Do and where to Do it","volume":"23","author":"Tuka","year":"2022","journal-title":"Rev Cardiovasc Med"},{"issue":"3","key":"10.1016\/j.ihj.2026.08.008_bib3","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1161\/CIR.0000000000001112","volume":"147","author":"Damluji","year":"2023","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ihj.2026.08.008_bib4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.31083\/j.rcm2404112","article-title":"New concepts on the pathophysiology of acute coronary syndrome","volume":"24","author":"Yuan","year":"2023","journal-title":"Rev Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.ihj.2026.08.008_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/eurheartj\/ehad720","article-title":"Platelet biology and function: plaque erosion vs. rupture","volume":"45","author":"Baaten","year":"2024","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.ihj.2026.08.008_bib6","article-title":"Comparison of the clinical manifestations of acute coronary syndrome between diabetic and non-diabetic patients: a systematic review and meta-analysis","volume":"16","author":"Tabowei","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.ihj.2026.08.008_bib7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4103\/jrms.jrms_695_21","article-title":"Molecular basis of acute coronary syndrome","volume":"27","author":"Balashkevich","year":"2022","journal-title":"J Res Med Sci"},{"key":"10.1016\/j.ihj.2026.08.008_bib8","article-title":"Multi-omics approaches for biomarker discovery and precision diagnosis of prediabetes","volume":"16","author":"Song","year":"2025","journal-title":"Front Endocrinol"},{"issue":"5","key":"10.1016\/j.ihj.2026.08.008_bib9","first-page":"338","article-title":"Integrative multi-omics analysis for etiology classification and biomarker discovery in stroke: advancing towards precision","volume":"13","author":"Labarga","year":"2024","journal-title":"Med Biol"},{"key":"10.1016\/j.ihj.2026.08.008_bib10","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3389\/fimmu.2019.00823","article-title":"Pentraxin 3 in Cardiovascular Disease","volume":"10","author":"Ristagno","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.ihj.2026.08.008_bib11","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3389\/fimmu.2019.00712","article-title":"The long pentraxin PTX3 as a link between innate immunity, tissue remodeling, and cancer","volume":"10","author":"Doni","year":"2019","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.ihj.2026.08.008_bib12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.advms.2024.07.010","article-title":"Pentraxin 3 as a marker of development and severity of stable coronary artery disease","volume":"69","author":"Knapp","year":"2024","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.ihj.2026.08.008_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.726289","article-title":"Higher plasma Pentraxin-3 level predicts adverse clinical outcomes in patients with coronary artery disease: a meta-analysis of cohort studies","volume":"8","author":"Ding","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"10.1016\/j.ihj.2026.08.008_bib14","first-page":"202","article-title":"Long-term prognostic significance of pentraxin-3 in patients with acute myocardial infarction: 5-year prospective cohort study","volume":"17","author":"Altay","year":"2017","journal-title":"Anatol J Cardiol"},{"key":"10.1016\/j.ihj.2026.08.008_bib15","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2147\/JIR.S393703","article-title":"Prognostic value of Pentraxin-3 change after primary percutaneous coronary intervention in patients with ST-Segment elevation myocardial infarction","volume":"16","author":"Li","year":"2023","journal-title":"J Inflamm Res"},{"issue":"4","key":"10.1016\/j.ihj.2026.08.008_bib16","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/ehf2.12728","article-title":"Growth differentiation factor 15 in adverse cardiac remodelling: from biomarker to causal player","volume":"7","author":"Wesseling","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.ihj.2026.08.008_bib17","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3389\/fphys.2018.01712","article-title":"GDF15 and growth control","volume":"9","author":"Emmerson","year":"2018","journal-title":"Front Physiol"},{"issue":"16","key":"10.1016\/j.ihj.2026.08.008_bib18","doi-asserted-by":"crossref","first-page":"8889","DOI":"10.3390\/ijms22168889","article-title":"GDF15 and cardiac cells: current concepts and new insights","volume":"22","author":"Rochette","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ihj.2026.08.008_bib19","article-title":"Growth differentiation factor-15, a novel systemic biomarker of oxidative stress, inflammation, and cellular aging: potential role in cardiovascular diseases","volume":"9","author":"di Candia","year":"2021","journal-title":"Am Heart J"},{"key":"10.1016\/j.ihj.2026.08.008_bib20","article-title":"Prognostic value of growth differentiation factor-15 in patients with coronary artery disease: a meta-analysis and systematic review","volume":"10","author":"Zhang","year":"2023","journal-title":"Front Cardiovasc Med"},{"issue":"7","key":"10.1016\/j.ihj.2026.08.008_bib21","doi-asserted-by":"crossref","first-page":"527","DOI":"10.26599\/1671-5411.2023.07.007","article-title":"Growth differentiation factor 15 predicts cardiovascular events in stable coronary artery disease","volume":"20","author":"Wang","year":"2023","journal-title":"J Geriatr Cardiol"},{"issue":"4","key":"10.1016\/j.ihj.2026.08.008_bib22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/eurheartj\/ehac577","article-title":"Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis","volume":"44","author":"Kato","year":"2023","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.ihj.2026.08.008_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182314","article-title":"GDF-15 predicts cardiovascular events in acute chest pain patients","volume":"12","author":"Tzikas","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ihj.2026.08.008_bib24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jjcc.2023.08.013","article-title":"Utility of growth differentiation factor-15 as a predictor of cardiovascular surgery outcomes: current research and future directions","volume":"83","author":"Shibasaki","year":"2024","journal-title":"J Cardiol"},{"issue":"1","key":"10.1016\/j.ihj.2026.08.008_bib25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/antiox13010132","article-title":"The roles of neutrophil-derived myeloperoxidase (MPO) in diseases: the new progress","volume":"13","author":"Lin","year":"2024","journal-title":"Antioxidants"},{"issue":"6","key":"10.1016\/j.ihj.2026.08.008_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3892\/br.2022.1536","article-title":"Role of myeloperoxidase in inflammation and atherosclerosis (Review)","volume":"16","author":"Frangie","year":"2022","journal-title":"Biomed Rep"},{"issue":"4","key":"10.1016\/j.ihj.2026.08.008_bib27","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3390\/antiox10040562","article-title":"The enzymatic and non-enzymatic function of myeloperoxidase (MPO) in inflammatory communication","volume":"10","author":"Kargapolova","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.ihj.2026.08.008_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2872607","article-title":"Prognostic role of elevated myeloperoxidase in patients with acute coronary syndrome: a systemic review and meta-analysis","volume":"2019","author":"Kolodziej","year":"2019","journal-title":"Mediat Inflamm"},{"issue":"2","key":"10.1016\/j.ihj.2026.08.008_bib29","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s12265-023-10425-2","article-title":"Neutrophil-Enriched biomarkers and long-term prognosis in acute coronary syndrome: a systematic review and meta-analysis","volume":"17","author":"Yiu","year":"2024","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.ihj.2026.08.008_bib30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/bs.apha.2017.08.002","article-title":"Matrix metalloproteinases, vascular remodeling, and vascular disease","volume":"81","author":"Wang","year":"2018","journal-title":"Adv Pharmacol"},{"issue":"1","key":"10.1016\/j.ihj.2026.08.008_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77413-3","article-title":"Identification of plaque ruptures using a novel discriminative model comprising biomarkers in patients with acute coronary syndrome","volume":"10","author":"Kook","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ihj.2026.08.008_bib32","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3872367","article-title":"The role of matrix Metalloproteinase-9 in atherosclerotic plaque instability","volume":"2020","author":"Li","year":"2020","journal-title":"Mediat Inflamm"},{"issue":"6","key":"10.1016\/j.ihj.2026.08.008_bib33","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3390\/life15060908","article-title":"Prognostic value of matrix metalloproteinase 9 (MMP9) in patients following off-pump coronary artery bypass grafting","volume":"15","author":"Popov","year":"2025","journal-title":"Life"},{"issue":"6","key":"10.1016\/j.ihj.2026.08.008_bib34","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1152\/physiol.00029.2013","article-title":"Matrix metalloproteinase-9: many shades of function in cardiovascular disease","volume":"28","author":"Yabluchanskiy","year":"2013","journal-title":"Physiology"},{"issue":"1","key":"10.1016\/j.ihj.2026.08.008_bib35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pharmthera.2013.03.009","article-title":"Matrix metalloproteinase (MMP)-9: a proximal biomarker for cardiac remodeling and a distal biomarker for inflammation","volume":"139","author":"Halade","year":"2013","journal-title":"Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.ihj.2026.08.008_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.107824","article-title":"Influence of matrix metalloproteinase 9 variant rs17576 on ischemic stroke risk and severity in acute coronary syndrome","volume":"33","author":"Bogari","year":"2024","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"2","key":"10.1016\/j.ihj.2026.08.008_bib37","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/cells14020106","article-title":"Osteopontin as a biomarker for coronary artery disease","volume":"14","author":"Layton","year":"2025","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.ihj.2026.08.008_bib38","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.3390\/biomedicines11123178","article-title":"The role of osteopontin in atherosclerosis and its clinical manifestations (atherosclerotic cardiovascular Diseases)-A narrative review","volume":"11","author":"Kadoglou","year":"2023","journal-title":"Biomedicines"},{"issue":"20","key":"10.1016\/j.ihj.2026.08.008_bib39","doi-asserted-by":"crossref","first-page":"9931","DOI":"10.3390\/ijms26209931","article-title":"Functional roles of the complement immune System in cardiac inflammation and hypertrophy","volume":"26","author":"Hok","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.ihj.2026.08.008_bib40","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11883-025-01279-x","article-title":"Inflammation-Driven plaque erosion in atherosclerosis: a focus on complement System pathways","volume":"27","author":"Ramoni","year":"2025","journal-title":"Curr Atheroscler Rep"},{"issue":"23","key":"10.1016\/j.ihj.2026.08.008_bib41","doi-asserted-by":"crossref","first-page":"9232","DOI":"10.3390\/ijms21239232","article-title":"Galectin-3 in cardiovascular diseases","volume":"21","author":"Blanda","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ihj.2026.08.008_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2025.1730173","article-title":"Galectin-3 in acute myocardial infarction: from molecular mechanisms to clinical translation","volume":"12","author":"Liu","year":"2025","journal-title":"Front Mol Biosci"},{"issue":"4","key":"10.1016\/j.ihj.2026.08.008_bib43","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/targets3040034","article-title":"Galectin-3: a multitasking protein linking cardiovascular diseases, immune disorders and beyond","volume":"3","author":"Morello","year":"2025","journal-title":"Targets"},{"issue":"12","key":"10.1016\/j.ihj.2026.08.008_bib44","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/mrc.5350","article-title":"Multiplatform untargeted metabolomics","volume":"61","author":"Jeppesen","year":"2023","journal-title":"Magn Reson Chem"},{"issue":"1","key":"10.1016\/j.ihj.2026.08.008_bib45","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1021\/acs.analchem.6b02930","article-title":"Interlaboratory reproducibility of a targeted metabolomics platform for analysis of human serum and plasma","volume":"89","author":"Siskos","year":"2017","journal-title":"Anal Chem"},{"issue":"2","key":"10.1016\/j.ihj.2026.08.008_bib46","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41569-022-00760-3","article-title":"Branched-chain amino acids in cardiovascular disease","volume":"20","author":"McGarrah","year":"2023","journal-title":"Nat Rev Cardiol"},{"issue":"8","key":"10.1016\/j.ihj.2026.08.008_bib47","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.3390\/biom13081252","article-title":"Divergent survival outcomes associated with elevated branched-chain amino acid levels among older adults with or without hypertension and diabetes: a validated, prospective, longitudinal Follow-Up Study","volume":"13","author":"Fung","year":"2023","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.ihj.2026.08.008_bib48","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.118.002157","article-title":"Circulating branched-chain amino acids and incident cardiovascular disease in a prospective cohort of US women","volume":"11","author":"Tobias","year":"2018","journal-title":"Circ Genom Precis Med"},{"issue":"7","key":"10.1016\/j.ihj.2026.08.008_bib49","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.3390\/ijms23074022","article-title":"The critical role of the branched chain amino acids (BCAAs) catabolism-regulating enzymes, branched-chain aminotransferase (BCAT) and Branched-Chain \u03b1-Keto Acid Dehydrogenase (BCKD), in human pathophysiology","volume":"23","author":"Dimou","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.ihj.2026.08.008_bib50","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.3390\/ijms24065742","article-title":"The tryptophan and Kynurenine pathway involved in the development of immune-related diseases","volume":"24","author":"Tsuji","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.ihj.2026.08.008_bib51","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1021\/acs.jproteome.1c00946","article-title":"Metabolomic workflow for the accurate and high-throughput exploration of the pathways of Tryptophan, tyrosine, phenylalanine, and branched-chain amino acids in human biofluids","volume":"21","author":"Anesi","year":"2022","journal-title":"J Proteome Res"},{"key":"10.1016\/j.ihj.2026.08.008_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.816301","article-title":"Role of ceramides in the molecular pathogenesis and potential therapeutic strategies of cardiometabolic diseases: what we know so far","volume":"9","author":"Shalaby","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"10.1016\/j.ihj.2026.08.008_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.advnut.2024.100252","article-title":"Ceramides as emerging players in cardiovascular disease: focus on their pathogenetic effects and regulation by diet","volume":"15","author":"Spaggiari","year":"2024","journal-title":"Adv Nutr"},{"issue":"9","key":"10.1016\/j.ihj.2026.08.008_bib54","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/cvr\/cvaf093","article-title":"Ceramides in cardiovascular disease: emerging role as independent risk predictors and novel therapeutic targets","volume":"121","author":"Klingenberg","year":"2025","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ihj.2026.08.008_bib55","article-title":"Impairment of ceramide-mediated endothelial instant membrane resealing during diabetes mellitus","volume":"13","author":"Chen","year":"2022","journal-title":"Front Physiol"},{"issue":"3","key":"10.1016\/j.ihj.2026.08.008_bib56","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1152\/physrev.00008.2023","article-title":"Ceramides are fuel gauges on the drive to cardiometabolic disease","volume":"104","author":"Wilkerson","year":"2024","journal-title":"Physiol Rev"},{"issue":"25","key":"10.1016\/j.ihj.2026.08.008_bib57","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/eurheartj\/ehw148","article-title":"Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol","volume":"37","author":"Laaksonen","year":"2016","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ihj.2026.08.008_bib58","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1186\/s12890-025-03884-7","article-title":"Exploring the association between ceramide, phosphatidylcholine, and COPD prevalence and incidence: a FINRISK population-based cohort study","volume":"25","author":"Shoghli","year":"2025","journal-title":"BMC Pulm Med"},{"issue":"12","key":"10.1016\/j.ihj.2026.08.008_bib59","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1161\/ATVBAHA.116.307497","article-title":"et alCirculating Ceramides Predict Cardiovascular Outcomes in the Population-Based FINRISK 2002 Cohort","volume":"36","author":"Havulinna","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"23","key":"10.1016\/j.ihj.2026.08.008_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252312511","article-title":"Microbiome-Derived trimethylamine N-Oxide (TMAO) as a multifaceted biomarker in cardiovascular disease: challenges and opportunities","volume":"25","author":"Jaworska","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ihj.2026.08.008_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1440241","article-title":"The association between the gut microbiota metabolite trimethylamine N-oxide and heart failure","volume":"15","author":"Jarmukhanov","year":"2024","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ihj.2026.08.008_bib62","first-page":"301","article-title":"Trimethylamine N-oxide (TMAO) in human health","volume":"20","author":"Gatarek","year":"2021","journal-title":"EXCLI J"},{"key":"10.1016\/j.ihj.2026.08.008_bib63","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4634172","article-title":"Trimethylamine N-Oxide generated by the Gut Microbiota is associated with vascular inflammation: new insights into atherosclerosis","volume":"2020","author":"Liu","year":"2020","journal-title":"Mediat Inflamm"},{"issue":"6","key":"10.1016\/j.ihj.2026.08.008_bib64","doi-asserted-by":"crossref","first-page":"936","DOI":"10.17305\/bb.2023.8893","article-title":"The roles of trimethylamine-N-oxide in atherosclerosis and its potential therapeutic aspect: a literature review","volume":"23","author":"Oktaviono","year":"2023","journal-title":"Biomol Biomed"},{"issue":"1","key":"10.1016\/j.ihj.2026.08.008_bib65","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s13105-023-00984-y","article-title":"Trimethylamine N-oxide promotes oxidative stress and lipid accumulation in macrophage foam cells via the Nrf2\/ABCA1 pathway","volume":"80","author":"Luo","year":"2024","journal-title":"J Physiol Biochem"},{"issue":"1","key":"10.1016\/j.ihj.2026.08.008_bib66","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1681\/ASN.2016030374","article-title":"Trimethylamine N-Oxide and cardiovascular events in hemodialysis patients","volume":"28","author":"Shafi","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ihj.2026.08.008_bib67","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ahj.2021.01.020","article-title":"Plasma trimethylamine N-oxide (TMAO) levels predict future risk of coronary artery disease in apparently healthy individuals in the EPIC-Norfolk prospective population study","volume":"236","author":"Tang","year":"2021","journal-title":"Am Heart J"},{"key":"10.1016\/j.ihj.2026.08.008_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102884","article-title":"Mitochondria in acute myocardial infarction and cardioprotection","volume":"57","author":"Ramachandra","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ihj.2026.08.008_bib69","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41467-019-13668-3","article-title":"Mitochondrial TCA cycle metabolites control physiology and disease","volume":"11","author":"Mart\u00ednez-Reyes","year":"2020","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.ihj.2026.08.008_bib70","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.3390\/ijms22084151","article-title":"Citric acid cycle metabolites predict infarct size in pigs submitted to transient coronary artery occlusion and treated with succinate dehydrogenase inhibitors or remote ischemic perconditioning","volume":"22","author":"Consegal","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.ihj.2026.08.008_bib71","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00395-019-0727-0","article-title":"Protection against cardiac ischemia-reperfusion injury by hypothermia and by inhibition of succinate accumulation and oxidation is additive","volume":"114","author":"Kohlhauer","year":"2019","journal-title":"Basic Res Cardiol"},{"issue":"1","key":"10.1016\/j.ihj.2026.08.008_bib72","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12933-021-01333-3","article-title":"Elevated plasma succinate levels are linked to higher cardiovascular disease risk factors in young adults","volume":"20","author":"Osuna-Prieto","year":"2021","journal-title":"Cardiovasc Diabetol"},{"issue":"21","key":"10.1016\/j.ihj.2026.08.008_bib73","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.3390\/jcm10215141","article-title":"Gender differences in the impact of new-onset atrial fibrillation on long-term risk of ischemic stroke after acute myocardial infarction","volume":"10","author":"Yi","year":"2021","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.ihj.2026.08.008_bib74","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/cvr\/cvab117","article-title":"EU-CardioRNA COST Action CA17129. Dissecting the transcriptome in cardiovascular disease","volume":"118","author":"Robinson","year":"2022","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10.1016\/j.ihj.2026.08.008_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygeno.2024.110878","article-title":"Transcriptomic responses of peripheral blood leukocytes to cardiac surgery after acute inflammation, and three months recovery","volume":"116","author":"Lewallen","year":"2024","journal-title":"Genomics"},{"key":"10.1016\/j.ihj.2026.08.008_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.908815","article-title":"Single-Cell RNA sequencing of peripheral blood mononuclear cells from acute myocardial infarction","volume":"13","author":"Qian","year":"2022","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.ihj.2026.08.008_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225137","article-title":"Investigating gene expression profiles of whole blood and peripheral blood mononuclear cells using multiple collection and processing methods","volume":"14","author":"Gautam","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ihj.2026.08.008_bib78","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1038\/s41467-021-25771-5","article-title":"Single-cell RNA sequencing of peripheral blood mononuclear cells from acute Kawasaki disease patients","volume":"12","author":"Wang","year":"2021","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.ihj.2026.08.008_bib79","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.3390\/biomedicines13122998","article-title":"Differential transcriptomic features of peripheral blood mononuclear cells in pulmonary sarcoidosis with and without extrapulmonary lesions in an East Asian population","volume":"13","author":"Murai","year":"2025","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.ihj.2026.08.008_bib80","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41420-025-02737-w","article-title":"Tracking NF-kB activity across steady-state neutrophil maturation","volume":"11","author":"Jeffries","year":"2025","journal-title":"Cell Death Discov"},{"issue":"4","key":"10.1016\/j.ihj.2026.08.008_bib81","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-096621","article-title":"Predictive value of novel inflammatory markers combined with GRACE score for in-hospital outcome in patients with ST-segment elevation myocardial infarction: a retrospective observational study","volume":"15","author":"Xin","year":"2025","journal-title":"BMJ Open"},{"issue":"13","key":"10.1016\/j.ihj.2026.08.008_bib82","first-page":"2537","article-title":"Heterogeneity of immune cells in human atherosclerosis revealed by scRNA-Seq","volume":"117","author":"Vallejo","year":"2021","journal-title":"Cardiovasc Res"},{"issue":"2","key":"10.1016\/j.ihj.2026.08.008_bib83","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202302001R","article-title":"Macrophage mediators and mechanisms in cardiovascular disease","volume":"38","author":"Schelemei","year":"2024","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.ihj.2026.08.008_bib84","doi-asserted-by":"crossref","DOI":"10.15212\/CVIA.2026.0001","article-title":"Emerging novel biomarkers in acute coronary syndrome management: insights and future directions","volume":"11","author":"Mittal","year":"2026","journal-title":"CVIA"},{"key":"10.1016\/j.ihj.2026.08.008_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102774","article-title":"TREM2 in cardiovascular diseases: mechanisms and therapeutic perspectives","volume":"109","author":"Zhu","year":"2025","journal-title":"Ageing Res Rev"},{"issue":"19","key":"10.1016\/j.ihj.2026.08.008_bib86","doi-asserted-by":"crossref","first-page":"9310","DOI":"10.3390\/ijms26199310","article-title":"Elevated Matrix metalloproteinase type 9 (MMP-9) transcripts after Thymoglobulin induction in incident Kidney Transplant recipients","volume":"26","author":"Petersen","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"24","key":"10.1016\/j.ihj.2026.08.008_bib87","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.3390\/ijms21249739","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases","volume":"21","author":"Cabral-Pacheco","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"21","key":"10.1016\/j.ihj.2026.08.008_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111939","article-title":"The antioxidant transcription factor Nrf2 in cardiac ischemia-reperfusion injury","volume":"22","author":"Mata","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.ihj.2026.08.008_bib89","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70268","article-title":"Oxidative stress: signaling pathways, biological functions, and disease","volume":"6","author":"Liu","year":"2020","journal-title":"MedComm"},{"issue":"4","key":"10.1016\/j.ihj.2026.08.008_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102745","article-title":"MicroRNA chemical modifications in post-transcriptional gene silencing and human diseases","volume":"36","author":"Alaei","year":"2025","journal-title":"Mol Ther Nucleic Acids"},{"issue":"13","key":"10.1016\/j.ihj.2026.08.008_bib91","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/1873-3468.70039","article-title":"The power of microRNA regulation-insights into immunity and metabolism","volume":"599","author":"Oliveto","year":"2025","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ihj.2026.08.008_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1676530","article-title":"et alAdvances in the role of extracellular vesicles in circulating microRNA biomarker discovery for lung cancer","volume":"13","author":"Belkozhayev","year":"2025","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"10.1016\/j.ihj.2026.08.008_bib93","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3390\/ijms21020561","article-title":"Challenges in using circulating Micro-RNAs as biomarkers for cardiovascular diseases","volume":"21","author":"Felekkis","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ihj.2026.08.008_bib94","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fcvm.2017.00073","article-title":"MiRroring the multiple potentials of MicroRNAs in acute myocardial infarction","volume":"4","author":"Paiva","year":"2017","journal-title":"Front Cardiovasc Med"},{"issue":"7","key":"10.1016\/j.ihj.2026.08.008_bib95","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3390\/cells8070737","article-title":"MicroRNAs in cardiac diseases","volume":"8","author":"Colpaert","year":"2019","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.ihj.2026.08.008_bib96","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.3390\/ijms22094799","article-title":"MicroRNAs in acute ST elevation myocardial Infarction-A new tool for diagnosis and prognosis: therapeutic implications","volume":"22","author":"Sc\u0103rl\u0103tescu","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"20","key":"10.1016\/j.ihj.2026.08.008_bib97","first-page":"307","article-title":"Change of plasma microRNA-208 level in acute myocardial infarction patients and its clinical significance","volume":"3","author":"Han","year":"2015","journal-title":"Ann Transl Med"},{"issue":"1","key":"10.1016\/j.ihj.2026.08.008_bib98","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s12872-024-04036-1","article-title":"Presentation, management, and early outcomes of young acute coronary syndrome patients- analysis of 23,560 South Asian patients from 2012 to 2021","volume":"24","author":"Peerwani","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"issue":"3","key":"10.1016\/j.ihj.2026.08.008_bib99","first-page":"4275","article-title":"Correlation between serum exosome derived miR-208a and acute coronary syndrome","volume":"8","author":"Bi","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.ihj.2026.08.008_bib100","article-title":"Diagnostic and prognostic significance of microRNA-208a in acute myocardial infarction","volume":"14","author":"Chen","year":"2022","journal-title":"Dis Markers"},{"issue":"3","key":"10.1016\/j.ihj.2026.08.008_bib101","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3390\/medsci13030172","article-title":"The Association of MicroRNA-21 with carotid artery disease and ischemic stroke: from pathophysiology to clinical implications and potential therapy","volume":"13","author":"Si\u010d","year":"2025","journal-title":"Med Sci"},{"key":"10.1016\/j.ihj.2026.08.008_bib102","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.767064","article-title":"miR-21 in human cardiomyopathies","volume":"8","author":"Surina","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"8","key":"10.1016\/j.ihj.2026.08.008_bib103","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1042\/CS20200023","article-title":"From animal models to patients: the role of placental microRNAs, miR-210, miR-126, and miR-148a\/152 in preeclampsia","volume":"134","author":"Frazier","year":"2020","journal-title":"Clin Sci (Lond)"},{"issue":"7","key":"10.1016\/j.ihj.2026.08.008_bib104","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.3390\/cells11071185","article-title":"The role of MicroRNAs in endothelial cell senescence","volume":"11","author":"Nikolajevic","year":"2022","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.ihj.2026.08.008_bib105","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3390\/biomedicines13020510","article-title":"Circulating microvesicles enriched in miR-126-5p and miR-223-3p: potential biomarkers in acute coronary syndrome","volume":"13","author":"Hern\u00e1ndez-L\u00f3pez","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.ihj.2026.08.008_bib106","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3389\/fimmu.2020.00625","article-title":"MicroRNA-155 implication in M1 polarization and the impact in inflammatory diseases","volume":"11","author":"Pasca","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ihj.2026.08.008_bib107","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3389\/fphar.2019.00463","article-title":"miR-155 in the resolution of atherosclerosis","volume":"10","author":"Bruen","year":"2019","journal-title":"Front Pharmacol"},{"issue":"21","key":"10.1016\/j.ihj.2026.08.008_bib108","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262110769","article-title":"MicroRNA signatures in cardiometabolic disorders as a next-generation diagnostic approach: current Insight","volume":"26","author":"Iside","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.ihj.2026.08.008_bib109","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.1111\/jcmm.14463","article-title":"miR-1, miR-499 and miR-208 are sensitive markers to diagnose sudden death due to early acute myocardial infarction","volume":"23","author":"Pinchi","year":"2019","journal-title":"J Cell Mol Med"},{"issue":"10","key":"10.1016\/j.ihj.2026.08.008_bib110","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.3390\/biom10101354","article-title":"Circulating microRNA as a biomarker for coronary artery disease","volume":"10","author":"Fazmin","year":"2020","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.ihj.2026.08.008_bib111","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ymthe.2025.08.047","article-title":"Epigenome editing based treatment: progresses and challenges","volume":"34","author":"Yuan","year":"2026","journal-title":"Mol Ther"},{"key":"10.1016\/j.ihj.2026.08.008_bib112","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2025.1632999","article-title":"Epigenetic modulation by life-style: advances in diet, exercise, and mindfulness for disease prevention and health optimization","volume":"12","author":"Ostaiza-Cardenas","year":"2025","journal-title":"Front Nutr"},{"issue":"47","key":"10.1016\/j.ihj.2026.08.008_bib113","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1093\/eurheartj\/ehx568","article-title":"Epigenetics and precision medicine in cardiovascular patients: from basic concepts to the clinical arena","volume":"39","author":"Costantino","year":"2018","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ihj.2026.08.008_bib114","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2018-000285","article-title":"DNA methylation 101: what is important to know about DNA methylation and its role in SLE risk and disease heterogeneity","volume":"5","author":"Lanata","year":"2018","journal-title":"Lupus Sci Med"},{"issue":"1","key":"10.1016\/j.ihj.2026.08.008_bib115","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s12964-023-01298-8","article-title":"DNA methylation and histone post-translational modifications in atherosclerosis and a novel perspective for epigenetic therapy","volume":"21","author":"Zhang","year":"2023","journal-title":"Cell Commun Signal"},{"issue":"1","key":"10.1016\/j.ihj.2026.08.008_bib116","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12872-021-01894-x","article-title":"Effect of ABCA1 promoter methylation on premature coronary artery disease and its relationship with inflammation","volume":"21","author":"An","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"10.1016\/j.ihj.2026.08.008_bib117","doi-asserted-by":"crossref","first-page":"7431","DOI":"10.1038\/s41467-024-51751-6","article-title":"Genome-wide DNA methylation profiling in blood reveals epigenetic signature of incident acute coronary syndrome","volume":"15","author":"Long","year":"2024","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.ihj.2026.08.008_bib118","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.292","article-title":"Post-translational modifications of histones: mechanisms, biological functions, and therapeutic targets","volume":"4","author":"Liu","year":"2020","journal-title":"MedComm"},{"issue":"3","key":"10.1016\/j.ihj.2026.08.008_bib119","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.261","article-title":"Protein posttranslational modifications in health and diseases: functions, regulatory mechanisms, and therapeutic implications","volume":"4","author":"Zhong","year":"2020","journal-title":"MedComm"},{"issue":"1","key":"10.1016\/j.ihj.2026.08.008_bib120","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13731","article-title":"HDAC3 in action: expanding roles in inflammation and inflammatory diseases","volume":"58","author":"He","year":"2025","journal-title":"Cell Prolif"},{"issue":"1","key":"10.1016\/j.ihj.2026.08.008_bib121","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41420-023-01399-w","article-title":"The role of HDAC3 and its inhibitors in regulation of oxidative stress and chronic diseases","volume":"9","author":"He","year":"2023","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.ihj.2026.08.008_bib122","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41419-023-05656-9","article-title":"Epigenetic mechanisms of Immune remodeling in sepsis: targeting histone modification","volume":"14","author":"Wu","year":"2023","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.ihj.2026.08.008_bib123","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/jcp.30579","article-title":"Dynamic alterations of H3K4me3 and H3K27me3 at ADAM17 and Jagged-1 gene promoters cause an inflammatory switch of endothelial cells","volume":"237","author":"Katakia","year":"2022","journal-title":"J Cell Physiol"},{"issue":"1","key":"10.1016\/j.ihj.2026.08.008_bib124","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/toxsci\/kfw203","article-title":"Long non-coding RNAs: a novel paradigm for toxicology","volume":"155","author":"Dempsey","year":"2017","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.ihj.2026.08.008_bib125","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ncrna.2025.01.004","article-title":"Long non-coding RNAs in humans: classification, genomic organization and function","volume":"11","author":"Chodurska","year":"2025","journal-title":"Noncoding RNA Res"},{"issue":"1","key":"10.1016\/j.ihj.2026.08.008_bib126","first-page":"41","article-title":"Association of ANRIL expression with coronary artery disease in type 2 diabetic patients","volume":"20","author":"Rahimi","year":"2018","journal-title":"Cell J"},{"issue":"12","key":"10.1016\/j.ihj.2026.08.008_bib127","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70076","article-title":"ANRIL's epigenetic regulation and its implications for cardiovascular disorders","volume":"38","author":"Moglad","year":"2024","journal-title":"J Biochem Mol Toxicol"},{"issue":"6","key":"10.1016\/j.ihj.2026.08.008_bib128","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0326212","article-title":"Integrated multi-omics analysis and predictive modeling of heart failure using sepsis-related gene signature","volume":"20","author":"Lang","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.ihj.2026.08.008_bib129","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1250340","article-title":"From multi-omics approaches to personalized medicine in myocardial infarction","volume":"10","author":"Zhan","year":"2023","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.ihj.2026.08.008_bib130","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1172\/JCI129202","article-title":"Integrative omics approaches provide biological and clinical insights: examples from mitochondrial diseases","volume":"130","author":"Khan","year":"2020","journal-title":"J Clin Investig"},{"issue":"17","key":"10.1016\/j.ihj.2026.08.008_bib131","doi-asserted-by":"crossref","first-page":"8429","DOI":"10.3390\/ijms26178429","article-title":"Molecular and immunomodulatory mechanisms of statins in inflammation and cancer therapeutics with emphasis on the NF-\u03baB, NLRP3 inflammasome, and cytokine regulatory axes","volume":"26","author":"Khan","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ihj.2026.08.008_bib132","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fimmu.2015.00262","article-title":"Complement System part I - molecular mechanisms of activation and regulation","volume":"6","author":"Merle","year":"2015","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.ihj.2026.08.008_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2023.152707","article-title":"Complement and coagulation crosstalk - factor H in the spotlight","volume":"228","author":"Heurich","year":"2023","journal-title":"Immunobiology"},{"key":"10.1016\/j.ihj.2026.08.008_bib134","article-title":"Variant-to-Biomarker pathways in peripheral artery disease: multiomics integration and clinical translation","volume":"29","author":"Wang","year":"2026","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ihj.2026.08.008_bib135","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2147\/VHRM.S279337","article-title":"Artificial intelligence in cardiovascular medicine: current insights and future prospects","volume":"18","author":"Haq","year":"2022","journal-title":"Vasc Health Risk Manag"},{"issue":"14","key":"10.1016\/j.ihj.2026.08.008_bib136","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.jacc.2020.08.011","article-title":"Inhibition of Interleukin-1\u03b2 and reduction in atherothrombotic cardiovascular events in the CANTOS trial","volume":"76","author":"Everett","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.ihj.2026.08.008_bib137","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.038687","article-title":"Cardiovascular benefit of colchicine in relation to baseline risk: a secondary analysis of the LoDoCo2 trial","volume":"14","author":"Mohammadnia","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ihj.2026.08.008_bib138","doi-asserted-by":"crossref","DOI":"10.4103\/jncd.jncd_49_26","article-title":"Acute coronary syndrome in a tertiary care setting: clinical characteristics, inflammatory profiles, and determinants of cardiogenic shock","author":"Mittal","year":"2026","journal-title":"International Journal of Noncommunicable Diseases"},{"key":"10.1016\/j.ihj.2026.08.008_bib139","article-title":"Inflammatory cytokine profiling across acute coronary syndrome subtypes: comparison of STEMI and NSTE-ACS","volume":"6","author":"Mittal","year":"2026","journal-title":"Indian Heart J"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483226001501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483226001501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:10:05Z","timestamp":1788606605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019483226001501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":139,"alternative-id":["S0019483226001501"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2026.08.008","relation":{},"ISSN":["0019-4832"],"issn-type":[{"value":"0019-4832","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-omics based biomarkers in acute coronary syndrome: Towards precision in cardiovascular medicine","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2026.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Cardiological Society of India. Published by Elsevier, a division of RELX India, Pvt. Ltd.","name":"copyright","label":"Copyright"}]}}